Literature DB >> 3039063

Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis.

S Ikeda, N Yanagisawa, M Hongo, N Ito.   

Abstract

To clarify the cause of gastrointestinal disorders in systemic amyloidosis we made pathologic and morphometric studies of vagus nerves, celiac ganglia, stomach and rectum in three autopsied cases with type 1 familial amyloid polyneuropathy (FAP) and two with nonhereditary generalized amyloidosis (AL-amyloidosis). The gastric and rectal walls in all cases were affected in the same way by amyloid deposition. On the other hand, there was a great difference between the two diseases in the severity of vagus nerve and celiac ganglion lesions: the vagus nerves in FAP showed very extensive endoneurial deposition of amyloid with severe loss of myelinated nerve fibers, but in AL-amyloidosis there was no loss of myelinated nerve fibers and only slight amyloid deposition in the endoneurium. Similarly, in the celiac ganglion, intraganglionic deposition of amyloid was prominent in FAP and slight in AL-amyloidosis. It is known that bowel symptoms frequently occur in type I FAP and are less prominent in AL-amyloidosis. This study demonstrated that the gastrointestinal autonomic nerves were more markedly disturbed by amyloid in the former than in the latter, and disorder in neural control of the digestive tract may be responsible for the bowel symptoms in systemic amyloidosis, especially in type I FAP.

Entities:  

Mesh:

Year:  1987        PMID: 3039063     DOI: 10.1016/0022-510x(87)90267-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy.

Authors:  O Suhr; A Danielsson; A Rydh; N Nyhlin; S O Hietala; L Steen
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

2.  Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells.

Authors:  M el-Salhy; O Suhr; R Stenling; E Wilander; L Grimelius
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

3.  Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy.

Authors:  J Wixner; P Karling; A Rydh; R Hörnsten; U Wiklund; I Anan; O B Suhr
Journal:  Neurogastroenterol Motil       Date:  2012-08-16       Impact factor: 3.598

4.  Frequency and characterization of celiac ganglia diagnosed on fine-needle aspiration.

Authors:  Ehab A ElGabry; Sara E Monaco; Liron Pantanowitz
Journal:  Cytojournal       Date:  2015-02-18       Impact factor: 2.091

5.  THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.

Authors:  Jonas Wixner; Rajiv Mundayat; Onur N Karayal; Intissar Anan; Pontus Karling; Ole B Suhr
Journal:  Orphanet J Rare Dis       Date:  2014-04-27       Impact factor: 4.123

6.  Glial cells in familial amyloidotic polyneuropathy.

Authors:  Nádia P Gonçalves; Susete Costelha; Maria J Saraiva
Journal:  Acta Neuropathol Commun       Date:  2014-12-18       Impact factor: 7.801

Review 7.  Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system.

Authors:  Isabel Conceição
Journal:  Clin Auton Res       Date:  2019-08-09       Impact factor: 4.435

Review 8.  Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.

Authors:  Laura Obici; Ole B Suhr
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

Review 9.  Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration.

Authors:  Francesco Gentile; Pietro Emiliano Doneddu; Nilo Riva; Eduardo Nobile-Orazio; Angelo Quattrini
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

10.  Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Konen Obayashi; Yukio Ando; Pontus Karling; Intissar Anan
Journal:  Amyloid       Date:  2013-05-03       Impact factor: 7.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.